Ambev (ABEV) operates in a country reeling under pandemic, but Brazilians continue to drink beer, revenue is growing and investor fear of Brazil will eventually subside as a commodity boom lifts its currency. This podcast (7:28) argues that Ambev is already increasing revenue while cyclical factors should help it cut costs, fueling a renewed look by investors at an emerging-markets company with a popular product and solid customer base.
Learn more about your ad choices. Visit megaphone.fm/adchoices